SQUAWK/NEWS
Menu
Live News EQUITY M impact

Medifast 8K Filing

Medifast files 8K with SEC, disclosing officer changes and financial statements. The filing includes results of shareholder vote and Regulation FD disclosure.

MED

Filed: 2026-05-26 AccNo: 0001628280-26-038109 Size: 386 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits